European Journal of Nanomedicine

Peter Wick, Savvina Chortarea, Olivier T. Guenat, Matthias Roesslein, Janick D. Stucki, Stephanie Hirn, Alke Petri-Fink & Barbara Rothen-Rutishauser


Engineered nanomaterials have unique and novel properties enabling wide-ranging new applications in nearly all fields of research. As these new properties have raised concerns about potential adverse effects for the environment and human health, extensive efforts are underway to define reliable, cost- and time-effective, as well as mechanistic-based testing strategies to replace the current method of animal testing, which is still the most prevalent model used for the risk assessment of chemicals. Current approaches for nanomaterials follow this line. The aim of this review is to explore and qualify the relevance of new in vitro and ex vivo models in (nano)material safety assessment, a crucial prerequisite for translation into applications.